Information and Communication Technology Based Centralized Clinical Trial Monitoring System for Insulin Dose Adjustment (ICT)
An Information and Communication Technology-based Centralized Clinical Trial to Determine the Efficacy and Safety of Insulin Dose Adjustment Education Based on a Smartphone Personal Health Record Application
Sponsor: Daegu Metropolitan City, Korea
Listed as NCT03112343, this NA trial focuses on Diabetes Mellitus and Insulin Hypoglycemia and remains completed. Sponsored by Daegu Metropolitan City, Korea, it has been updated 9 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
May 2019 — Jan 2021 [monthly]
Completed NA
Status: Recruiting → Completed
▶ Show 4 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Dec 2017 — Feb 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
May 2017 — Dec 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Daegu Metropolitan City, Korea
- ICT Clinical Trial Coordination Center
- Korea Evaluation Institute of Industrial Technology
- Ministry of Trade, Industry & Energy, Republic of Korea
- Samsung Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .